Mutations in loricrin are associated with loricrin keratoderma [38] loss-of-function mutation in SCTA (cystatin A) can induce autosomal recessive exfoliative ichthyosis and acral peeling skin syndrome [39,40]. Here, LORICRIN is linked to exfoliative ichthyosis.